Your browser doesn't support javascript.
loading
Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study.
Fox, Peter; Balleine, Rosemary L; Lee, Clara; Gao, Bo; Balakrishnar, Bavanthi; Menzies, Alexander M; Yeap, Shang Heng; Ali, Sayed Sahanawaz; Gebski, Val; Provan, Pamela; Coulter, Sally; Liddle, Christopher; Hui, Rina; Kefford, Richard; Lynch, Jodi; Wong, Mark; Wilcken, Nicholas; Gurney, Howard.
Afiliación
  • Fox P; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Balleine RL; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Pathology West, Institute for Clinical Pathology and Medical Research, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia. Westmead Millennium Institute for Medical Research, Westme
  • Lee C; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Gao B; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia.
  • Balakrishnar B; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Menzies AM; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Yeap SH; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Ali SS; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Gebski V; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia.
  • Provan P; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia.
  • Coulter S; Westmead Millennium Institute for Medical Research, Westmead, Australia.
  • Liddle C; Sydney Medical School - Westmead, University of Sydney, Sydney, Australia. Westmead Millennium Institute for Medical Research, Westmead, Australia. Storr Liver Centre, Westmead Hospital, Westmead, Australia.
  • Hui R; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia.
  • Kefford R; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia.
  • Lynch J; St George Hospital, Kogarah, Australia.
  • Wong M; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia.
  • Wilcken N; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia.
  • Gurney H; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, Australia. Sydney Medical School - Westmead, University of Sydney, Sydney, Australia. Faculty of Medicine and Health Sciences, Macquarie University, Sydney Australia. howard.gurney@mq.edu.au.
Clin Cancer Res ; 22(13): 3164-71, 2016 07 01.
Article en En | MEDLINE | ID: mdl-26847054

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Monitoreo de Drogas / Antineoplásicos Hormonales / Citocromo P-450 CYP2D6 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Tamoxifeno / Neoplasias de la Mama / Monitoreo de Drogas / Antineoplásicos Hormonales / Citocromo P-450 CYP2D6 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos